Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spotlight on Q1 Pharma M&A Merry-Go-Round

Executive Summary

Q1 2019 saw a jump in merger and acquisition activity. Informa’s Biomedtracker has cast an analytical eye on three of the major deals, namely buys by Roche, Lilly and BMS.

Advertisement

Related Content

Deal Watch: Vertex Expands Gene-Editing Efforts With A Pair Of Deals
BioMarin Says It's Got The Hemophilia Therapy Data For Approval And Value
As Expected: Shareholders Back Bristol's $74bn Celgene Buy
Roche Confident Spark Therapeutics Acquisition Will Complete In First Half
'Totality Of Data' Make A Case For Luspatercept In Beta-Thalassemia, MDS

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC125339

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel